openPR Logo
Press release

Rising desire for minimally invasive treatments propels the growth of the Overactive Bladder Treatment Market| Astellas Pharma Inc., Teva Pharmaceutical Industries Ltd., Pfizer Inc.

08-31-2023 01:40 PM CET | Health & Medicine

Press release from: Global Insight Services

Rising desire for minimally invasive treatments propels

Overactive bladder (OAB) is a condition characterized by frequent, sudden urges to urinate that may disrupt sleep or everyday activities. It is caused by involuntary contractions of the bladder muscle that cause leakage of urine or a strong, sudden urge to urinate. OAB is a common condition, affecting millions of people around the world.

Treatment for overactive bladder typically begins with lifestyle modifications such as cutting back on caffeine and alcohol, avoiding bladder irritants, and scheduling regular bathroom trips. Pelvic floor exercises such as Kegels can also help strengthen the muscles that control urination.

Other treatments for OAB include medications, such as anticholinergics, which help relax the bladder muscle and reduce symptoms. Botox injections may also be used to relax the bladder muscle and reduce symptoms.

In severe cases, a surgical procedure called sacral nerve stimulation (SNS) may be used to treat OAB. SNS involves the implantation of a device that sends electrical signals to the sacral nerve. These signals help to reduce the frequency and urgency of urination.

In addition to lifestyle modifications and medications, other treatments for OAB may include biofeedback, electrical stimulation, and nerve stimulation therapies. Biofeedback is a type of therapy that teaches people how to control their bladder muscles. Electrical stimulation therapy involves applying electrical impulses to the muscles of the bladder to reduce bladder contractions. Nerve stimulation therapy involves using electrical currents to stimulate the nerves in the bladder and can help reduce symptoms of OAB.

Overall, the treatment for overactive bladder depends on the severity of the condition. Lifestyle modifications, medications, and other treatments may be used to reduce symptoms and improve quality of life.

Download Sample PDF Of This Report:
https://www.globalinsightservices.com/request-sample/GIS24888

Key Drivers
Overactive bladder (OAB) is a medical condition that is characterized by sudden, frequent, and urgent need to urinate, as well as frequent urination during the day and night. It is estimated that OAB affects approximately 33 million people in the United States. The primary drivers of the Overactive Bladder Treatment Market are the increasing prevalence of OAB, the introduction of new treatments, and the increasing demand for minimally invasive treatments.

The prevalence of OAB is increasing globally due to the aging population, as well as the increasing prevalence of lifestyle-related diseases, such as diabetes and obesity, which can contribute to OAB. In addition, the introduction of new treatments, such as Botox injections, has increased the availability of treatment options for OAB.

The increasing demand for minimally invasive treatments is also driving the market. Minimally invasive treatments, such as Botox injections, are gaining popularity as they are less invasive than traditional treatments and can provide relief with fewer side effects.

In addition, the increasing awareness of OAB and its treatments is driving the market. The increasing awareness of OAB is due to the increasing number of campaigns and initiatives that are raising awareness of the condition. This has increased the demand for treatment options as people are more aware of the condition and its treatments.

The availability of reimbursement policies is also driving the market. Reimbursement policies enable people to access treatments that are not covered by their insurance plans, which increases the demand for treatment options.

Lastly, technological advances in the development of novel treatments are also driving the market. The development of novel treatments, such as stem cell therapy, has enabled the development of treatments that are more effective and have fewer side effects.

In conclusion, the key drivers of the Overactive Bladder Treatment Market are the increasing prevalence of OAB, the introduction of new treatments, the increasing demand for minimally invasive treatments, the increasing awareness of OAB and its treatments, the availability of reimbursement policies, and the technological advances in the development of novel treatments. These drivers are expected to continue to drive the market in the future.

Request Customization:
https://www.globalinsightservices.com/request-customization/GIS24888

Market Segmentation
The Overactive Bladder Treatment market can be segmented by drug type, disease type, and region.By drug type, the market can be divided into anticholinergic solifenacin, oxybutynin, tolterodine, darifenacin mirabegron, botox, and neuromodulation. By disease type, the market can be divided into idopathic oab, and neurogenic oab. By region, the market is divided into North America, Europe, Asia Pacific, and the Rest of the World.

Key Players
The market includes players such as Astellas Pharma Inc. (Japan), Teva Pharmaceutical Industries Ltd. (Israel), Pfizer Inc. (US), Medtronic Pic (Ireland), AbbVie Inc. (US), Viatris Inc. (US), Hisamitsu Pharmaceutical Co., Inc. (Japan), Johnson & Johnson Services, Inc. (US), Endo Pharmaceuticals Inc. (Ireland), Macleods Pharmaceuticals Ltd(IN).

Procure Complete Report (pdf with Insights, Charts, Tables, and Figures)
https://www.globalinsightservices.com/checkout/single_user/GIS24888

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

New Report Published by Global Insight Services: https://www.globalinsightservices.com/reports/hydrogen-projects-database/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rising desire for minimally invasive treatments propels the growth of the Overactive Bladder Treatment Market| Astellas Pharma Inc., Teva Pharmaceutical Industries Ltd., Pfizer Inc. here

News-ID: 3190437 • Views:

More Releases from Global Insight Services

U.S. and Colorado RTD Cocktail Market Overview by Rising Demands and Scope 2024 to 2033
U.S. and Colorado RTD Cocktail Market Overview by Rising Demands and Scope 2024 …
Market Definition An RTD cocktail is a pre-mixed alcoholic beverage that is typically sold in a can or bottle. RTD cocktails are convenient because they require no additional mixing or preparation, making them ideal for parties or other events where alcohol will be served. There are a variety of RTD cocktails available, including popular options such as Moscow Mules, Margaritas, and Bloody Marys. RTD cocktails are typically made with lower-quality alcohol,
Space Semiconductor Market Booming Across the Globe by Growth, Segments and Forecast 2033
Space Semiconductor Market Booming Across the Globe by Growth, Segments and Fore …
Market Definition A space semiconductor is a type of semiconductor device that is designed to function in extreme conditions found in outer space. Space semiconductors must be able to withstand high levels of radiation and extreme temperatures, as well as the vacuum of space. Space semiconductors are used in a variety of space-based applications, including satellites, spacecraft, and telescopes. They are also used in space exploration missions, such as the Mars
E-passport Market A Deep Dive Into Market Size, Share, And Trends By 2033 | Mühlbauer Group, Primekey Solutions Ab, Thales Group, Safran
E-passport Market A Deep Dive Into Market Size, Share, And Trends By 2033 | Müh …
Market Definition The E-passport Market represents a transformative shift in travel documentation, offering enhanced security and efficiency compared to traditional passports. Also known as biometric passports, E-passports incorporate a microprocessor chip containing the holder's biometric information, such as fingerprints and facial recognition data, along with personal details. This technology not only mitigates the risk of identity theft and fraud but also expedites border control processes by enabling automated authentication. Market Outlook The E-passport
Oligonucleotide Synthesis Market Share, Size 2024 Global Comprehensive Research Study, Trends, Development Status, Opportunities, Future Plans, Competitive Landscape And Growth By Forecast 2033
Oligonucleotide Synthesis Market Share, Size 2024 Global Comprehensive Research …
Market Definition The Oligonucleotide Synthesis Market is a vital component in the biotechnology and pharmaceutical industries, providing customized strands of DNA or RNA sequences for various applications such as genetic research, diagnostics, and therapeutic development. This market encompasses a range of synthesis technologies, including solid-phase synthesis and enzymatic methods, allowing researchers to tailor oligonucleotides with precision. As advancements in genomics, personalized medicine, and synthetic biology drive demand for high-quality oligonucleotides, the

All 5 Releases


More Releases for OAB

Overactive Bladder (OAB) - Drug Pipeline Landscape, 2022
Overactive bladder (OAB) is a condition in which the bladder muscle contracts too often and causes urinary frequency, urgency, and incontinence. It affects both men and women, but is more common in women. The causes of overactive bladder include neurological disorders, such as stroke, multiple sclerosis and eak pelvic muscles, diabetes, urinary tract infections, excess consumption of caffeine or alcohol, declining cognitive function due to aging, difficulty walking. The most common symptoms
Overactive Bladder (OAB) Therapeutics Market to Witness Huge Growth by 2028 | Te …
Understanding customer behavior towards particular product or service and target audience plays vital role to strengthen the position in the marketplace. This Overactive Bladder (OAB) Therapeutics market analysis sheds light on key points and measures to follow for business growth. It focuses on a wide array of business facets including pillars, planning models, sales strategies and features. It also covers principal data related to major players, their adopted strategies, competitive
Overactive Bladder (OAB) Treatment- Global Market Outlook 2019-2024
Global Overactive Bladder Treatment Market, delivering a must-read report for industry stakeholders wanting to understand the strategic landscape of this burgeoning sector. Readers will find an in-depth analysis of the market and how it will impact existing traditional markets, as well as insights into future development and opportunities across the globe. MarketInsightsReports has announced the addition of the "Global Overactive Bladder Treatment Market Research Report 2018" The report focuses on global
Global OAB Treatment Market Growth (Status and Outlook) 2019-2024
LP INFORMATION offers a latest published report on OAB Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the OAB Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular,
Overactive Bladder (OAB) Therapeutics Market: Global Industry Analysis and Forec …
Overactive bladder is a medical syndrome, defined by urinary incontinence usually characterized by high urine frequency or nocturia. The common symptoms of OAB includes urgency, high urinary frequency and urge incontinence. Anticholinergic agents are considered as the first line treatment for overactive bladder disorders. Flavoxate, oxybutynin, tolterodine are some of the generic drugs used for the treatment of overactive bladder. These drugs acts by antagonizing cholinergic receptors that provides the
Overactive Bladder (OAB) Therapeutics Market to Perceive Substantial Growth Duri …
Overactive bladder is a medical syndrome, defined by urinary incontinence usually characterized by high urine frequency or nocturia. The common symptoms of OAB includes urgency, high urinary frequency and urge incontinence. Anticholinergic agents are considered as the first line treatment for overactive bladder disorders. Flavoxate, oxybutynin, tolterodine are some of the generic drugs used for the treatment of overactive bladder. These drugs acts by antagonizing cholinergic receptors that provides the